Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 3”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Large-scale testing (Phase 3)Study completedNCT05934526
What this trial is testing

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Who this might be right for
Pulmonary Arterial Hypertension
GB002, Inc. 390
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Large-scale testing (Phase 3)Study completedNCT04576988
What this trial is testing

Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 324
Testing effectiveness (Phase 2)Study completedNCT00454558
What this trial is testing

An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 75
Large-scale testing (Phase 3)Ended earlyNCT01210443
What this trial is testing

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Who this might be right for
Hypertension, Pulmonary
Pfizer 2
Large-scale testing (Phase 3)Ended earlyNCT00796510
What this trial is testing

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 3
Large-scale testing (Phase 3)Active Not RecruitingNCT04273945
What this trial is testing

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 935
Large-scale testing (Phase 3)Ended earlyNCT00796666
What this trial is testing

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 131
Large-scale testing (Phase 3)Ended earlyNCT02725372
What this trial is testing

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Who this might be right for
Pulmonary Arterial Hypertension
Bellerophon Pulse Technologies 207
Large-scale testing (Phase 3)Study completedNCT01743001
What this trial is testing

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 226
Large-scale testing (Phase 3)Ended earlyNCT00795639
What this trial is testing

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 183
Large-scale testing (Phase 3)Study completedNCT04732221
What this trial is testing

The Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Who this might be right for
Pulmonary Arterial HypertensionHypertension, Pulmonary
Merck Sharp & Dohme LLC 168
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Large-scale testing (Phase 3)Looking for participantsNCT07481981
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Insmed Incorporated 344
Large-scale testing (Phase 3)Ended earlyNCT05036135
What this trial is testing

AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aerovate Therapeutics 202
Large-scale testing (Phase 3)Study completedNCT00423202
What this trial is testing

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 186
Large-scale testing (Phase 3)WithdrawnNCT02436512
What this trial is testing

Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide

Who this might be right for
Pulmonary Arterial Hypertension
Geno LLC
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Who this might be right for
PAHPulmonary HypertensionHypertension+8 more
United Therapeutics 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Large-scale testing (Phase 3)Study completedNCT01908699
What this trial is testing

Beraprost-314d Added-on to Tyvaso® (BEAT)

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 273
Load More Results